CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Hci Viocare  (VICA)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Equipment & Supplies
 
 

VICA's Revenue Year on Year Growth by Quarter and Year

Hci Viocare's Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
VICA Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 0.04 0.01 -0.06
III Quarter September - 0.46 0.02 0.02
II Quarter June 0.13 0.05 0.03 -
I Quarter March 0.09 0.14 0.01 -
FY   0.22 0.69 0.07 -0.04

Financial Statements
Hci Viocare's second quarter 2017 Revenue $ 0.13 millions VICA's Income Statement
Hci Viocare's second quarter 2016 Revenue $ 0.05 millions Quarterly VICA's Income Statement
VICA's Growth by Division See VICA's Growth by Segment

VICA Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - 300 % - -
III Quarter September - 2200 % 0 % -
II Quarter June 166.52 % 66.67 % - -
I Quarter March -35.71 % 1300 % - -
FY   - 885.71 % - -



VICA Revenue Growth Comment
Hci Viocare reported Revenue surge of 166.52% year on year in the second quarter, to $ 0.13 millions, this is lower than Hci Viocare's recent average Revenue surge of 651.8%.

Looking into second quarter results within Medical Equipment & Supplies industry 3 other companies have achieved higher Revenue growth. While Hci Viocare' s Revenue doubling of 166.52% ranks overall at the positon no. 133 in the second quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #4
Healthcare Sector #37
Overall #133
Revenue Y/Y Growth Statistics
High Average Low
2541.83 % 651.8 % -38.49 %
(Sep 30 2016)   (Mar 31 2017)

You need to upgrade your Flash Player

Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
VICA's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for VICA's Competitors
Revenue Growth for Hci Viocare's Suppliers
Revenue Growth for VICA's Customers

You may also want to know
VICA's Annual Growth Rates VICA's Profitability Ratios VICA's Asset Turnover Ratio VICA's Dividend Growth
VICA's Roe VICA's Valuation Ratios VICA's Financial Strength Ratios VICA's Dividend Payout Ratio
VICA's Roa VICA's Inventory Turnover Ratio VICA's Growth Rates VICA's Dividend Comparisons



Companies with similar Revenue doubling for the quarter ending Jun 30 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2017
Zogenix, Inc.  241.24 %$ 241.236 millions
Steadymed Ltd.  239.36 %$ 239.362 millions
Arbutus Biopharma Corp  236.25 %$ 236.246 millions
Apollo Medical Holdings, Inc.  236.05 %$ 236.054 millions
Neos Therapeutics, Inc.  230.57 %$ 230.572 millions
Inovio Pharmaceuticals, Inc.  229.03 %$ 229.027 millions
Chemocentryx, Inc.  219.75 %$ 219.750 millions
Ptc Therapeutics, Inc.  206.80 %$ 206.800 millions
Bellicum Pharmaceuticals, Inc.  203.96 %$ 203.960 millions
Cti Biopharma Corp.  201.93 %$ 201.929 millions
Orexigen Therapeutics, Inc.  199.78 %$ 199.782 millions
Enzon Pharmaceuticals, Inc.  198.20 %$ 198.195 millions
Cytomx Therapeutics, Inc.  182.87 %$ 182.870 millions
Regenxbio Inc.  176.29 %$ 176.295 millions
Hci Viocare  175.23 %$ 175.234 millions
Exact Sciences Corp  172.11 %$ 172.108 millions
Ionis Pharmaceuticals Inc  170.74 %$ 170.736 millions
Novavax Inc  168.74 %$ 168.743 millions
Invitae Corp  156.87 %$ 156.872 millions
Biolargo, Inc.  156.45 %$ 156.446 millions
Rewalk Robotics Ltd.  145.65 %$ 145.655 millions
Viewray, Inc.  133.44 %$ 133.445 millions
Second Sight Medical Products Inc  115.62 %$ 115.622 millions
Novocure Ltd  114.16 %$ 114.164 millions
Geovax Labs, Inc.  111.77 %$ 111.774 millions
Kite Pharma, Inc.  109.64 %$ 109.635 millions
U.s. Stem Cell, Inc.  104.34 %$ 104.345 millions
Innovus Pharmaceuticals, Inc.  99.96 %$ 99.962 millions
Adamis Pharmaceuticals Corp  97.36 %$ 97.363 millions
Biocept Inc  92.95 %$ 92.946 millions